Okada, Norio
Iwama, Shintaro http://orcid.org/0000-0002-3281-0337
Okuji, Takayuki
Kobayashi, Tomoko
Yasuda, Yoshinori
Wada, Eri
Onoue, Takeshi
Goto, Motomitsu
Sugiyama, Mariko
Tsunekawa, Taku
Takagi, Hiroshi
Hagiwara, Daisuke
Ito, Yoshihiro
Suga, Hidetaka
Banno, Ryoichi
Hase, Tetsunari
Morise, Masahiro
Kanda, Mitsuro http://orcid.org/0000-0001-5464-3819
Yokota, Kenji
Hashimoto, Naozumi
Ando, Masahiko
Fujimoto, Yasushi
Nagino, Masato
Kodera, Yasuhiro
Fujishiro, Mitsuhiro
Hibi, Hideharu
Sone, Michihiko
Kiyoi, Hitoshi
Gotoh, Momokazu
Ando, Yuichi
Akiyama, Masashi
Hasegawa, Yoshinori
Arima, Hiroshi
Article History
Received: 21 September 2019
Revised: 20 December 2019
Accepted: 14 January 2020
First Online: 3 February 2020
Ethics approval and consent to participate
: This study was approved by the Ethical Committee of Nagoya University Hospital (approval number: 2015-0273), and was performed in accordance with the Declaration of Helsinki. All enrolled patients provided written informed consent before any of the study-specific procedures were performed. Clinical trial information: ExternalRef removed no. UMIN000019024 (registered September 15, 2015).
: We obtained consent for publication from all patients in this study.
: All data included in this study are available upon request, sent to the corresponding author.
: S.I. is a consultant/advisory board member for endocrinological adverse events at Ono Pharmaceutical Company and Bristol-Myers Squibb, and receives fees for presentations, consulting and advising, and the writing of published materials from Ono Pharmaceutical Company, Bristol-Myers Squibb and MSD K.K. T.H. receives personal fees from Ono Pharmaceutical Company, Bristol-Myers Squibb and MSD K.K. M.M. receives personal fees from Ono Pharmaceutical Company, Bristol-Myers Squibb and MSD K.K. M.N. receives a grant from Bristol-Myers Squibb. Y.K. receives grants and personal fees from Ono Pharmaceutical Company, Bristol-Myers Squibb and MSD K.K. M.F. receives personal fees from Ono Pharmaceutical Company, and MSD K.K. H.K. receives grants and personal fees from Ono Pharmaceutical Company and Bristol-Myers Squibb, and MSD K.K. M.G. receives grants from Ono Pharmaceutical Company. Y.A. receives grants from Ono Pharmaceutical Company and personal fees from Ono Pharmaceutical Company and Bristol-Myers Squibb. M.Ak. receives grants from Ono Pharmaceutical Company, and MSD K.K. Y.H. receives grants and personal fees from Ono Pharmaceutical Company and Bristol-Myers Squibb, and MSD K.K. H.A. receives grants from Ono Pharmaceutical Company. MSD K.K. receives personal fees from Ono Pharmaceutical Company and Bristol-Myers Squibb. The remaining authors have nothing to disclose.
: The authors declare no funding support.